New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2013
07:36 EDTOFIX, BONE, ARTC, ZMH, RTIX, VSCI, CNMD, OSIRCanaccord to host a conference
Musculoskeletal Conference is being held in Chicago on March 19.
News For OSIR;OFIX;BONE;ARTC;ZMH;RTIX;VSCI;CNMD From The Last 14 Days
Check below for free stories on OSIR;OFIX;BONE;ARTC;ZMH;RTIX;VSCI;CNMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 28, 2014
06:29 EDTZMHZimmer upgraded to Outperform from Perform at Oppenheimer
July 24, 2014
15:11 EDTZMHZimmer valuation not reflecting Biomet deal potential, says Cantor
Cantor says Zimmer remains its preferred name in orthopedics despite its "disappointing" Q2 report, as the firm believes the stock's valuation doesn't properly reflects the potential from its tie-up with Biomet. Cantor thinks Zimmer management's synergy targets are possibly conservative and raised its price target on the stock to $117 from $113.
08:27 EDTZMHZimmer 'confident' Biomet merger transaction to be completed in 1Q15
Subscribe for More Information
08:25 EDTZMHZimmer sees FY14 gross margin ratio at 73%-74%
Expects FY14 SG&A to be unchanged, although it says there will be a seasonally higher ratio in Q3. Sees FY14 tax rate of 25.5%.
08:25 EDTZMHZimmer sees Q3 EPS $1.29-$1.31, consensus $1.37
Subscribe for More Information
08:19 EDTZMHLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
08:09 EDTRTIXRTI Surgical sees Q3 EPS 2c, consensus 2c
Subscribe for More Information
08:08 EDTRTIXRTI Surgical raises FY14 EPS ex-items 9c-11c from 7c-9c, consensus 8c
Subscribe for More Information
08:07 EDTRTIXRTI Surgical reports Q2 EPS 3c, consensus 2c
Reports Q2 revenue $66M, consensus $59.20M.
07:48 EDTZMHZimmer cuts FY14 EPS to $6.00-$6.10 from $6.00-$6.20, consensus $6.12
Subscribe for More Information
07:47 EDTZMHZimmer reports Q2 adjusted EPS $1.49, consensus $1.49
Reports Q2 revenue $1.18b, consensus $1.21B
July 23, 2014
16:00 EDTCNMDCONMED price target lowered to $43 from $50 at Piper Jaffray
Subscribe for More Information
07:31 EDTBONEBacterin announces 1 for 10 reverse split of common stock
Bacterin announced that a 1:10 reverse split of its common stock will be effective at the close of business on Friday, July 25 and in effect for trading purposes on Monday, July 28. The reverse stock split was approved by the company's shareholders at the 2014 Annual Shareholder's Meeting held June 11.
07:09 EDTCNMDCONMED lowers FY14 adjusted EPS view to $1.85-$1.95 from $1.90-$2.00
Subscribe for More Information
07:06 EDTCNMDCONMED reports Q2 adjusted EPS 47c, consensus 47c
Subscribe for More Information
07:05 EDTCNMDCONMED CEO Corasanti steps down, Curt Hartman appointed Interim CEO
Subscribe for More Information
06:58 EDTCNMDCONMED trading halted, pending news
Subscribe for More Information
July 22, 2014
08:15 EDTZMHZimmer should be bought on any weakness from Q2 results, says RBC Capital
RBC Capital believes that consensus Q2 recon estimates for Zimmer may be "a bit optimistic," but the firm thinks that investors already partially anticipate a miss on that metric The firm recommends buying the stock on any weakness associated with Q2 results, as it thinks the company's valuation is favorable, given its growth outlook. RBC Capital keeps a $120 price target and Outperform rating on the shares.
July 21, 2014
18:00 EDTBONEBacterin reports preliminary Q2 revenue $8.75M-$8.85M, consensus $8.93M
The company sees preliminary Q2 operating loss ($1.5M)-($1.4M). The company sees preliminary Q2 EBITDA of ($800K)-($900K). Gross margin for Q2 is expected to be 61%-63%.
July 16, 2014
07:18 EDTOFIXScoliosis Research Society to hold annual meeting
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use